Medtronic plc — Director's Dealing 2018

Mar 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-03-02

Reporting Person: Surface Carol A (SVP, Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-02	Ordinary Shares	S	12000	$78.00	Disposed	42010	Direct
2018-03-05	Ordinary Shares	S	12479	$78.36	Disposed	29531	Direct
2018-03-05	Ordinary Shares	M	24719	$57.65	Acquired	54250	Direct
2018-03-05	Ordinary Shares	M	22706	$62.76	Acquired	76956	Direct
2018-03-05	Ordinary Shares	M	1195	$62.76	Acquired	78151	Direct
2018-03-05	Ordinary Shares	F	40338	$79.74	Disposed	37813	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-05	Stock Option (Right to Buy)	$57.65	M	24719	Disposed	2023-10-28	Ordinary Shares (24719)	Direct
2018-03-05	Stock Option (Right to Buy)	$62.76	M	22706	Disposed	2024-07-28	Ordinary Shares (22706)	Direct
2018-03-05	Stock Option (Right to Buy)	$62.76	M	1195	Disposed	2024-07-28	Ordinary Shares (1195)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1092	Indirect

Footnotes

F1: This balance increased by 140 shares due to exempt transactions such as dividend reinvestment.

F2: The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.340 to $78.440, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

F3: This option to purchase 32,958 New Medtronic ordinary shares for $57.65 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 32,958 Medtronic common stock shares for $57.65 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F5: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.